Filing Flows › LifeMD (LFMD) › Q2 2026 › vs Q2 2025
LifeMD (LFMD) Q2 2026 vs Q2 2025 (year over year)
LifeMD's revenue fell $1.7M (-4%) from $49.0M in Q2 2025 to $47.3M in Q2 2026. The biggest changes: Telehealth −$2.0M (-10%); Telehealth Subscription Revenue +$254K (+0.9%).
LifeMD, Q2 2026: revenue $47.3M (-4% year over year), operating margin -15.1%, net loss $7.1M, operating cash flow −$6.9M. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Telehealth Subscription Revenue | $29.3M | $29.0M | $254K | +0.9% |
| Telehealth | $18.0M | $20.0M | −$2.0M | -10% |
| Revenue | $47.3M | $49.0M | −$1.7M | -4% |
| Net loss | $7.1M | $1.1M | $6.0M | +536% |
| Costs & expenses | $54.4M | $52.0M | $2.4M | +5% |
| Operating costs | $54.4M | $51.4M | $3.0M | +6% |
| Cost of revenue | $5.3M | $6.8M | −$1.6M | -23% |
| Sales & marketing | $28.0M | $22.2M | $5.9M | +27% |
| General & admin | $13.6M | $14.4M | −$793K | -5% |
| Other operating costs | $7.4M | $7.9M | −$492K | -6% |
| Operating cash sources | $8.0M | −$6.3M | $14.4M | — |
| Depreciation & amortization | $325K | $199K | $126K | +63% |
| Share-based compensation | $790K | $2.1M | −$1.3M | -62% |
| Cash used in operations | $6.9M | −$8.6M | $15.6M | — |
| Net loss absorbed | $7.1M | $1.1M | $6.0M | +536% |
| Working capital & other | $957K | −$7.5M | $8.4M | — |
Questions
How much did LifeMD's revenue grow year over year in Q2 2026?
LifeMD's revenue fell $1.7M (-4%) from $49.0M in Q2 2025 to $47.3M in Q2 2026.
What drove LifeMD's revenue change in Q2 2026?
Telehealth −$2.0M (-10%); Telehealth Subscription Revenue +$254K (+0.9%).